Evidence map›Paper›PMID 33881537›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2021

Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese-Exposed Workers.

Susan R Criswell, Susan Searles Nielsen, Wendy W Dlamini, Mark N Warden, Joel S Perlmutter, Lianne Sheppard, Stephen M Moerlein, Jason Lenox-Krug, Harvey Checkoway, Brad A Racette

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Susan R CriswellDepartment of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Susan Searles NielsenDepartment of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Wendy W DlaminiDepartment of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Mark N WardenDepartment of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Joel S PerlmutterDepartment of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Lianne SheppardDepartment of Environmental and Occupational Health Sciences, University of Washington, School of Public Health, Seattle, Washington 98195, USA.
Stephen M MoerleinDepartment of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Jason Lenox-KrugDepartment of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Harvey CheckowayDepartment of Family Medicine and Public Health, University of California, San Diego, School of Medicine, La Jolla, California 92093, USA.
Brad A RacetteDepartment of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Washington University in St. Louis · USUniversity of California, San Diego · USUniversity of the Witwatersrand · ZAUniversity of Washington · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
WILDLIFE BIOMARKER APPLICATIONS TO REMEDIATION DECISION MAKINGP42ES004696 · NIEHS · UNIVERSITY OF WASHINGTON · PI GALLAGHER, EVAN P · 1987 to 2021
$51.2M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Imaging Biomarkers of Neurotoxicity in WeldersR01ES021488 · NIEHS · WASHINGTON UNIVERSITY · PI Brad A Racette · 2013 to 2026
$5.3M
NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITYR01ES029524 · NIEHS · WASHINGTON UNIVERSITY · PI CRISWELL, SUSAN · 2019 to 2023
$3.3M
Epidemiology of Parkinsonism in WeldersR01ES013743 · NIEHS · WASHINGTON UNIVERSITY · PI RACETTE, BRAD A · 2007 to 2011
$2.6M
Epidemiology and Biomarkers of Parkinsonism in WeldersK24ES017765 · NIEHS · WASHINGTON UNIVERSITY · PI RACETTE, BRAD A · 2009 to 2018
$1.5M
RESTING STATE FUNCTIONAL CONNECTIVITY MRI IN MANGANESE EXPOSED WELDERSK23ES021444 · NIEHS · WASHINGTON UNIVERSITY · PI CRISWELL, SUSAN · 2012 to 2016
$809k
A Nationwide Study of Environmental Risk Factors for Parkinson DiseaseK01ES028295 · NIEHS · WASHINGTON UNIVERSITY · PI SEARLES NIELSEN, SUSAN · 2018 to 2020
$450k
Advanced Research Center at Washington UniversityAmerican Parkinson Disease AssociationNCATS NIH HHS UL1 TR002345NCRR NIH HHS UL1 RR024992NIEHS NIH HHS K01 ES028295NIEHS NIH HHS K23 ES021444NIEHS NIH HHS K24 ES017765NIEHS NIH HHS P42 ES004696NIEHS NIH HHS R01 ES013743NIEHS NIH HHS R01 ES021488NIEHS NIH HHS R01 ES029524NIH HHS R01ES021488
6 · The paper itself

Abstract

The relationships between the neurotoxicant manganese (Mn), dopaminergic pathology, and parkinsonism remain unclear. Therefore, we used [11C](N-methyl)benperidol (NMB) positron emission tomography to investigate the associations between Mn exposure, striatal and extrastriatal D2 dopamine receptors (D2R), and motor function in 54 workers with a range of Mn exposure. Cumulative Mn exposure was estimated from work histories, and all workers were examined by a movement specialist and completed a Grooved Pegboard test (GPT). NMB D2R nondisplaceable binding potentials (BPND) were calculated for brain regions of interest. We identified 2 principal components (PCs) in a PC analysis which explained 66.8% of the regional NMB BPND variance (PC1 = 55.4%; PC2 = 11.4%). PC1 was positively correlated with NMB binding in all regions and inversely correlated with age. PC2 was driven by NMB binding in 7 brain regions (all p < .05), positively in the substantia nigra, thalamus, amygdala, and medial orbital frontal gyrus and negatively in the nucleus accumbens, anterior putamen, and caudate. PC2 was associated with both Mn exposure status and exposure duration (years). In addition, PC2 was associated with higher Unified Parkinson's Disease Rating Scale motor subsection 3 (UPDRS3) scores and slower GPT performance. We conclude Mn exposure is associated with both striatal and extrastriatal D2R binding. Multifocal alterations in D2R expression are also associated with motor dysfunction as measured by both the GPT and UPDRS3, demonstrating a link between Mn exposure, striatal and extrastriatal D2R expression, and clinical neurotoxicity.

Indexed as

ManganesePositron-Emission TomographyBrainCorpus StriatumHumansPrincipal Component AnalysisManganeseD2 receptorsmanganesePCAPET

Identifiers

PMID33881537
PMCPMC8285020
OpenAlexW3153321094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.